Nichols William Garrett (CIK 1618364) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-07-30). Recent activity: Buy CADL (937 shares), Sell CADL (937 shares), Buy CADL (781 shares), Sell CADL (781 shares), Buy CADL (4,584 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-07-30 | Candel Therapeutics, Inc. (CADL) | Chief Medical Officer | Buy | 937 | $1,209 |
| 2025-07-30 | Candel Therapeutics, Inc. (CADL) | Chief Medical Officer | Sell | 937 | $6,540 |
| 2025-07-02 | Candel Therapeutics, Inc. (CADL) | Chief Medical Officer | Buy | 781 | $1,007 |
| 2025-07-02 | Candel Therapeutics, Inc. (CADL) | Chief Medical Officer | Sell | 781 | $3,936 |
| 2025-03-20 | Candel Therapeutics, Inc. (CADL) | Chief Medical Officer | Buy | 4,584 | $17,190 |
| 2025-03-20 | Candel Therapeutics, Inc. (CADL) | Chief Medical Officer | Buy | 13,905 | $17,937 |
| 2025-03-20 | Candel Therapeutics, Inc. (CADL) | Chief Medical Officer | Sell | 45,316 | $396,968 |
| 2025-01-17 | Candel Therapeutics, Inc. (CADL) | Chief Medical Officer | Sell | 10,428 | $75,394 |
Source: SEC Form 4 filings · as of 2025-07-30